Top Section/Ad
Top Section/Ad
Most recent
Novo Nordisk bought £50m of the deal leaving £30m for the market
Flurry of deals in euros with more to come as Monday supply already beats last week’s total volume
Third step of Clariane's four-legged debt restructuring plan was 1.67 times oversubscribed
Evidence grows that companies can sell bonds successfully any day of the week
More articles/Ad
More articles/Ad
More articles
-
Valuation mismatch between issuer and investors prompted the decision to cancel the IPO -
Online pharmacy concludes the issue of convertible bonds, a delta placement and a tender offer
-
The first IPO in more than three years probably won’t reignite the Portuguese market
-
Like Renk and Douglas, Galderma has turned to the loan market over bonds after floating
-
The biggest IPO of 2024 so far in Europe has delivered a welcome bounce in the aftermarket
-
Galderma will provide the European IPO market with another important data point when it begins trading on Friday
